慢性阻塞性肺病是否源于不同的细胞类型?
Yohannes Tesfaigzi1, Jeffrey L Curtis2,3, Irina Petrache4,5
1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
American journal of respiratory cell and molecular biology
|August 16, 2023
概括
慢性阻塞性肺病 (COPD) 的发病是复杂的. 了解早期细胞类型的敏感性是澄清COPD异质性和开发向疗法的关键.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 慢性阻塞性肺病 (COPD) 呈现异质的临床表现,使诊断和治疗复杂化.
- 目前的COPD亚型依赖于晚期疾病样本,限制了对早期病原体的理解.
- 独特的COPD表型可能源于在早期疾病阶段对环境侮辱的差异性细胞类型敏感性.
研究的目的:
- 审查目前有关肺细胞类型的知识,以启动COPD病原发生.
- 识别COPD表型和遗传关联中细胞类型特定作用的知识差距.
- 突出新技术在阐明COPD病理生理学和异质性方面的潜力.
主要方法:
- 文献综述和综合现有关于COPD病原学的研究.
- 专注于关键肺细胞种群的易感性,包括巨细胞,淋巴细胞和上皮细胞.
- 讨论新兴技术,如单细胞转录组学和蛋白质组学.
主要成果:
- 巨细胞,T和B细胞,巨细胞,树突细胞,内皮细胞和呼吸道上皮细胞都与早期COPD发病有关.
- 关于哪些特定的细胞类型驱动着独特的COPD表型和疾病阶段,存在重大知识差距.
- 各种细胞类型在介导COPD遗传风险因素中的作用在很大程度上尚不清楚.
结论:
- 了解特定肺细胞类型对环境因素的敏感性对于破译COPD异质性至关重要.
- 先进的单细胞和蛋白质组技术为解决COPD病理生理学和临床变异性提供了有希望的途径.
- 需要进一步的研究来将特定的细胞类型与不同的COPD表型和遗传倾向联系起来.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.3K
01:20COPD: Pathogenesis and Clinical Features
344
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
344
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K